Literature DB >> 30334869

Where Do People Go for Gonorrhea and Chlamydia Tests: A Cross-Sectional View of the Central Indiana Population, 2003-2014.

Teresa A Batteiger, Brian E Dixon, Jane Wang1, Zuoyi Zhang1, Guoyu Tao2, Yan Tong1, Wanzhu Tu, Sarah A Hoover1, Janet N Arno.   

Abstract

BACKGROUND: Despite major efforts to control their spread, reported sexually transmitted infections (STI) are increasing. Using data from a mid-sized Midwest metropolitan area, we examined the settings in which individuals are tested for gonorrhea and chlamydia in relation to demographics and test result to determine where interventions may best be focused.
METHODS: A deidentified and integrated registry, containing records from all patients tested for an STI from 2003 to 2014, was created by combining data from a large health information exchange and the reporting district's STI Program located in Indianapolis, IN. Individual characteristics and visit settings where gonorrhea and chlamydia testing was performed were analyzed.
RESULTS: We identified 298,946 individuals with 1,062,369 visits where testing occurred at least once between the ages of 13 and 44 years. Females were tested significantly more often than males and received testing more often in outpatient clinics whereas males were most often tested in the STI clinic. Individuals who used both STI and non-STI settings were more likely to have a positive test at an STI or emergency department visit (6.4-20.8%) than outpatient or inpatient setting (0.0-11.3%) (P < 0.0001). Test visits increased over the study period particularly in emergency departments, which showed a substantial increase in the number of positive test visits.
CONCLUSIONS: The most frequent testing sites remain STI clinics for men and outpatient clinics for women. Yet, emergency departments (ED) are increasingly a source of testing and morbidity. This makes them a valuable target for public health interventions that could improve care and population health.

Entities:  

Mesh:

Year:  2019        PMID: 30334869     DOI: 10.1097/OLQ.0000000000000928

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  6 in total

1.  Emergency Department Testing Patterns for Sexually Transmitted Diseases in North Texas.

Authors:  Arti Barnes; Katelyn K Jetelina; Andrea C Betts; Theresa Mendoza; Pranavi Sreeramoju; Jasmin A Tiro
Journal:  Sex Transm Dis       Date:  2019-07       Impact factor: 2.830

2.  Gonorrhea testing, morbidity, and reporting using an integrated sexually transmitted disease registry in Indiana: 2004-2016.

Authors:  Opeyemi C Ojo; Janet N Arno; Guoyu Tao; Chirag G Patel; Zuoyi Zhang; Jane Wang; Justin Holderman; Brian E Dixon
Journal:  Int J STD AIDS       Date:  2020-09-30       Impact factor: 1.359

Review 3.  Sexually Transmitted Infection Epidemiology and Care in Rural Areas: A Narrative Review.

Authors:  Wiley D Jenkins; Leslie D Williams; William S Pearson
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

4.  Improving care for sexually transmitted infections.

Authors:  Cornelis A Rietmeijer
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

5.  Chlamydia trachomatis bacterial load, estimated by Cq values, in urogenital samples from men and women visiting the general practice, hospital or STI clinic.

Authors:  Juliën N A P Wijers; Christian J P A Hoebe; Geneviève A F S van Liere; Petra F G Wolffs; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

6.  Validation of International Classification of Diseases, Tenth Revision, Clinical Modification Codes for Identifying Cases of Chlamydia and Gonorrhea.

Authors:  Yenling Andrew Ho; Saurabh Rahurkar; Guoyu Tao; Chirag G Patel; Janet N Arno; Jane Wang; Andrea A Broyles; Brian E Dixon
Journal:  Sex Transm Dis       Date:  2021-05-01       Impact factor: 3.868

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.